Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
female patients, \>=18 years of age;
breast cancer;
CNS progression after radio-surgery + whole brain radiotherapy, or whole brain radiotherapy alone;
at least one measurable lesion;
ECOG performance status 0-2.
You may not be if
prior systemic treatment of brain metastases;
prior disease progression while on Xeloda treatment;
previous history of cancer (other than curatively treated basal and squamous cell cancer of the skin or in situ cancer of the cervix) in previous 5 years;
